BAXTER INTERNATIONAL INC (BAX) Insider Transactions
Over the last 12 months, 20 BAXTER INTERNATIONAL INC (BAX) insiders filed 49 SEC Form 4 transactions — $0 in open-market purchases ( 0 distinct buyers) and $0 in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $0Open-market buys (1y)
- $0Open-market sells (1y)
- 20Distinct insiders
- 49Transactions filed
- 0%Under Rule 10b5-1 plan
- 2026-06-02Latest filing
Recent Form 4 Filings Most recent 49 of 49 (1-year window)
Each row is a single Form 4 filing event for BAX, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.
| Date | Insider | Title | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Wallace Steven P. | President, Adv. Surgery | Other | F | $2.9K | 153 | $18.68 |
| 2026-06-02 | Teaff James | President, CCS | Other | F | $6.0K | 321 | $18.68 |
| 2026-06-01 | Zielinski Anita A | SVP, Interim CFO, CAO & Cntrlr | Grant | A | $0 | 13,426 | $0.00 |
| 2026-05-05 | Wilkes David S. | — | Grant | A | $0 | 12,836 | $0.00 |
| 2026-05-05 | Wendell Amy McBride | — | Grant | A | $0 | 12,836 | $0.00 |
| 2026-05-05 | SCHLICHTING NANCY M | — | Grant | A | $0 | 12,836 | $0.00 |
| 2026-05-05 | MORRISON PATRICIA | — | Grant | A | $0 | 12,836 | $0.00 |
| 2026-05-05 | Shafer David Brent | — | Grant | A | $0 | 12,836 | $0.00 |
| 2026-05-05 | McDonnell Michael R. | — | Grant | A | $0 | 12,836 | $0.00 |
| 2026-05-05 | Craig Jeffrey A | — | Grant | A | $0 | 12,836 | $0.00 |
| 2026-05-05 | Ampofo William A. II | — | Grant | A | $0 | 12,836 | $0.00 |
| 2026-03-06 | Zielinski Anita A | SVP, CAO and Controller | Grant | — | $34.2K | 1,932 | $17.69 |
| 2026-03-06 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant | — | $50.4K | 2,848 | $17.69 |
| 2026-03-06 | Rosenbloom David S. | EVP and General Counsel | Grant | — | $117.1K | 6,620 | $17.69 |
| 2026-03-06 | Rasul Reazur | EVP,Group Pres,Healthcare | Grant | — | $224.2K | 12,674 | $17.69 |
| 2026-03-06 | Grade Joel T. | EVP and CFO | Grant | — | $144.2K | 8,153 | $17.69 |
| 2026-03-02 | Rasul Reazur | EVP,Group Pres,Healthcare | Grant | — | $31.8K | 1,614 | $19.69 |
| 2026-03-02 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant | — | $36.5K | 1,852 | $19.69 |
| 2026-03-02 | Rosenbloom David S. | EVP and General Counsel | Grant | — | $26.3K | 1,336 | $19.69 |
| 2026-02-27 | Hider Andrew P. | President and CEO | Grant | — | $0 | 201,804 | $0.00 |
| 2026-02-27 | Hider Andrew P. | President and CEO | Grant | — | $0 | 488,506 | $0.00 |
| 2026-02-27 | Carlisle Cynthia | Executive Vice President, CHRO | Grant | — | $0 | 17,806 | $0.00 |
| 2026-02-27 | Carlisle Cynthia | Executive Vice President, CHRO | Grant | — | $0 | 11,871 | $0.00 |
| 2026-02-27 | Carlisle Cynthia | Executive Vice President, CHRO | Grant | — | $0 | 43,103 | $0.00 |
| 2026-02-27 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant | — | $0 | 23,742 | $0.00 |
| 2026-02-27 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant | — | $0 | 57,471 | $0.00 |
| 2026-02-27 | Rosenbloom David S. | EVP and General Counsel | Grant | — | $0 | 26,709 | $0.00 |
| 2026-02-27 | Rosenbloom David S. | EVP and General Counsel | Grant | — | $0 | 64,655 | $0.00 |
| 2026-02-27 | Grade Joel T. | EVP and CFO | Grant | — | $0 | 42,735 | $0.00 |
| 2026-02-27 | Grade Joel T. | EVP and CFO | Grant | — | $0 | 103,448 | $0.00 |
| 2026-02-27 | Zielinski Anita A | SVP, CAO and Controller | Grant | — | $0 | 30,864 | $0.00 |
| 2026-02-13 | McDonnell Michael R. | — | Grant | — | $0 | 1,811 | $0.00 |
| 2026-02-09 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant | — | $0 | 2,273 | $0.00 |
| 2026-02-09 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant | — | $19.9K | 918 | $21.73 |
| 2026-02-09 | Rosenbloom David S. | EVP and General Counsel | Grant | — | $0 | 17,055 | $0.00 |
| 2026-02-09 | Rosenbloom David S. | EVP and General Counsel | Grant | — | $113.5K | 5,225 | $21.73 |
| 2026-02-09 | Rasul Reazur | EVP,Group Pres,Healthcare | Grant | — | $0 | 18,951 | $0.00 |
| 2026-02-09 | Rasul Reazur | EVP,Group Pres,Healthcare | Grant | — | $125.4K | 5,770 | $21.73 |
| 2026-02-09 | Grade Joel T. | EVP and CFO | Grant | — | $0 | 30,504 | $0.00 |
| 2026-02-09 | Grade Joel T. | EVP and CFO | Grant | — | $198.7K | 9,144 | $21.73 |
| 2025-12-12 | Mason Jeanne K | EVP, Chief HR Officer | Grant | — | $12.4K | 650 | $19.15 |
| 2025-12-01 | Grade Joel T. | EVP and CFO | Grant | — | $158.1K | 8,288 | $19.08 |
| 2025-09-02 | Sonig Alok | EVP,Group President,Pharma | Grant | — | $77.1K | 3,191 | $24.17 |
| 2025-09-02 | Hider Andrew P. | President and CEO | Grant | — | $0 | 236,237 | $0.00 |
| 2025-09-02 | Hider Andrew P. | President and CEO | Grant | — | $0 | 131,813 | $0.00 |
| 2025-09-02 | Hider Andrew P. | President and CEO | Grant | — | $0 | 465,651 | $0.00 |
| 2025-09-02 | Grade Joel T. | EVP and CFO | Grant | — | $0 | 102,712 | $0.00 |
| 2025-09-02 | Borzi James W | EVP,Chief Supply Chain Officer | Grant | — | $44.7K | 1,848 | $24.17 |
| 2025-08-19 | Shafer David Brent | — | Grant | — | $762.4K | 31,337 | $24.33 |
Methodology & FAQ
How We Track BAX Insider Transactions
Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.
What is an SEC Form 4 filing for BAXTER INTERNATIONAL INC?
Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of BAXTER INTERNATIONAL INC (BAX) shares.
What is a Rule 10b5-1 trading plan?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.
How is "insider buying" different from a stock grant or option exercise?
An insider buy (SEC transaction code P) is an open-market purchase of BAXTER INTERNATIONAL INC (BAX) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.
How recent is the data?
Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.